TYGERA PHARMA Trademark
Trademark Overview
On Monday, September 24, 2018, a trademark application was filed for TYGERA PHARMA with the United States Patent and Trademark Office. The USPTO has given the TYGERA PHARMA trademark a serial number of 79254927. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, May 8, 2026. This trademark is owned by Nordic Nanovector AS. The TYGERA PHARMA trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical preparations and substances, namely, pharmaceutical preparations and substances for use in hematology, oncology and for the treatment of cancer; reagents for medical use; medical diagnostic chemicals and medical diagnostic reagents for medical use; antibody-based chemicals and reagents for medical use, namely, monoclonal antibodies, immuno-radiotherapies, antibody-radionuclide-conjugates; radiotherapies in the nature of chemotherapeutics that have a similar mechanism of action; diagnostic assay test kits for medical use consisting of medical diagnostic chemicals and reagents; biochemical preparations, namely, antibodies for medical diagnostic and therapeutic use
Medical and pharmaceutical research and development, namely, medical and pharmaceutical research and development in the field of hematology, oncology and the treatment of cancer; conducting clinical trials for others, namely, conducting clinical trials in the field of hematology, oncology and the treatment of cancer; providing medical research and scientific research information, namely, in the field of hematology, oncology and the treatment of cancer
Medical services; medical services in the field of healing, in particular diagnostic services in the field of hematology, oncology and the treatment of cancer; medical services, namely, immuno-radiotherapies and radiotherapies in the field of hematology, oncology and the treatment of cancer
General Information
| Serial Number | 79254927 |
| Word Mark | TYGERA PHARMA |
| Filing Date | Monday, September 24, 2018 |
| Status | 709 - CANCELLED - SECTION 71 |
| Status Date | Friday, May 8, 2026 |
| Registration Number | 5887785 |
| Registration Date | Tuesday, October 22, 2019 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 6, 2019 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations and substances, namely, pharmaceutical preparations and substances for use in hematology, oncology and for the treatment of cancer; reagents for medical use; medical diagnostic chemicals and medical diagnostic reagents for medical use; antibody-based chemicals and reagents for medical use, namely, monoclonal antibodies, immuno-radiotherapies, antibody-radionuclide-conjugates; radiotherapies in the nature of chemotherapeutics that have a similar mechanism of action; diagnostic assay test kits for medical use consisting of medical diagnostic chemicals and reagents; biochemical preparations, namely, antibodies for medical diagnostic and therapeutic use |
| NOT AVAILABLE | "PHARMA" |
| Goods and Services | Medical and pharmaceutical research and development, namely, medical and pharmaceutical research and development in the field of hematology, oncology and the treatment of cancer; conducting clinical trials for others, namely, conducting clinical trials in the field of hematology, oncology and the treatment of cancer; providing medical research and scientific research information, namely, in the field of hematology, oncology and the treatment of cancer |
| Goods and Services | Medical services; medical services in the field of healing, in particular diagnostic services in the field of hematology, oncology and the treatment of cancer; medical services, namely, immuno-radiotherapies and radiotherapies in the field of hematology, oncology and the treatment of cancer |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, May 8, 2026 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, May 8, 2026 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, May 8, 2026 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Nordic Nanovector AS |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 84 - NOT AVAILABLE |
| Address | NO |
| Party Name | Nordic Nanovector AS |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 84 - NOT AVAILABLE |
| Address | NO |
| Party Name | Nordic Nanovector AS |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 84 - NOT AVAILABLE |
| Address | NO |
Trademark Events
| Event Date | Event Description |
| Thursday, March 21, 2019 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, March 25, 2019 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Tuesday, April 2, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, April 2, 2019 | ASSIGNED TO EXAMINER |
| Friday, April 5, 2019 | NON-FINAL ACTION WRITTEN |
| Saturday, April 6, 2019 | APPLICATION FILING RECEIPT MAILED |
| Saturday, April 6, 2019 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, April 29, 2019 | REFUSAL PROCESSED BY MPU |
| Monday, April 29, 2019 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, May 18, 2019 | REFUSAL PROCESSED BY IB |
| Tuesday, June 18, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, June 18, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, June 18, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, June 20, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, July 1, 2019 | ASSIGNED TO LIE |
| Wednesday, July 17, 2019 | NOTICE OF PUBLICATION |
| Tuesday, August 6, 2019 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 22, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, January 22, 2020 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Saturday, February 15, 2020 | GENERIC MADRID TRANSACTION CREATED |
| Saturday, February 15, 2020 | GENERIC MADRID TRANSACTION SENT TO IB |
| Friday, March 13, 2020 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, November 22, 2024 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, May 8, 2026 | CANCELLED SECTION 71 |
